Singular Genomics Systems Inc
NASDAQ:OMIC 4:00:00 PM EDT
| Market Cap (Intraday) | 199.20M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.76 |
| 50-Day MA | $2.25 |
| 200-Day MA | $2.95 |
Singular Genomics Systems Inc Stock, NASDAQ:OMIC
3010 Science Park Road, Suite 100, San Diego, California 92121
United States of America
Phone: +1.858.333.7830
Number of Employees: 221
Description
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.